Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data.

Lee, Chung-Shien; Milone, Matthew; Seetharamu, Nagashree

Lee, Chung-Shien; Milone, Matthew; Seetharamu, Nagashree.

Afiliação

Lee CS; Department of Clinical Health Professions, St. John's University, Queens, NY, USA.
Milone M; Division of Medical Oncology and Hematology, Northwell Health Cancer Institute, Lake Success, NY, USA.
Seetharamu N; Pharmacy Department, Long Island Jewish Medical Center, New Hyde Park, NY, USA.

Onco Targets Ther ; 14: 4579-4597, 2021.

Article em En | MEDLINE | ID: mdl-34471361

Palavras-chave

epidermal growth factor receptor; non-small cell lung cancer; osimertinib; tyrosine kinase inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article